Health TrialsbyHealthPanel

Fear of Recurrence and Stopping Immunotherapy

ConditionCognitive Behavioral Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Pittsburgh

About this trial

The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 21 years and older

Fluent in English

Diagnosis of cancer and history of treatment with immunotherapy

Disqualifiers

Active suicidal ideation, delusions or hallucinations

Trial design

Design model

Single group

Treatments tested in this trial

  • cognitive behavioral therapy

    Behavioral

    Cognitive-behavioral therapy involves changing these erroneous cognitions and beliefs through cognitive restructuring, modification of behavior, and development of alternative coping skills.

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Cessation of treatmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Reduce fear of recurrence

Change by 50%

Time frame
3 months

Secondary outcomes

1

Improve quality of life

Change of quality of life by 5 points

Time frame
3 months
2

Reduction of anxiety

Change of anxiety by 2 points

Time frame
3 months
3

Depressive symptoms

Change by 25%

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pittsburgh

Lead sponsor

Source ClinicalTrials.gov
Apply now